Equity

Corporate Results

Vaishali Pharma standalone net profit declines 6.40% in the December 2021 quarter
(21-Jan-2022, 17:50 Hours IST)  
Net profit of Vaishali Pharma declined 6.40% to Rs 1.61 crore in the quarter ended December 2021 as against Rs 1.72 crore during the previous quarter ended December 2020. Sales rose 4.28% to Rs 22.18 crore in the quarter ended December 2021 as against Rs 21.27 crore during the previous quarter ended December 2020.

ParticularsQuarter Ended
 Dec. 2021Dec. 2020% Var.
Sales22.1821.27 4
OPM %11.2312.69 -
PBDT2.252.43 -7
PBT2.152.32 -7
NP1.611.72 -6

Powered by Capital Market - Live News

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)